1、 JIN K T, LU Z B, LV J Q, et al. The role of long non-coding RNAs in mediating chemoresistance by modulating autophagy in cancer[J]. RNA Biol,2020, 17(12):1727-1740. JIN K T, LU Z B, LV J Q, et al. The role of long non-coding RNAs in mediating chemoresistance by modulating autophagy in cancer[J]. RNA Biol,2020, 17(12):1727-1740.
2、 MATSUSHITA M, FREIGANG S, SCHNEIDER C, et al. T cell lipid peroxidation induces ferroptosis and prevents immunity to infection[J]. J Exp Med,2015, 212(4):555-568. MATSUSHITA M, FREIGANG S, SCHNEIDER C, et al. T cell lipid peroxidation induces ferroptosis and prevents immunity to infection[J]. J Exp Med,2015, 212(4):555-568.
3、 YAGODA N, von RECHENBERG M, ZAGANJOR E, et al. RAS-RAF-MEK-dependent oxidative cell death involving voltage-dependent anion channels[J]. Nature,2007, 447(7146):864-868. YAGODA N, von RECHENBERG M, ZAGANJOR E, et al. RAS-RAF-MEK-dependent oxidative cell death involving voltage-dependent anion channels[J]. Nature,2007, 447(7146):864-868.
4、 DIXON S J, LEMBERG K M, LAMPRECHT M R, et al. Ferroptosis: an iron-dependent form of nonapoptotic cell death[J]. Cell,2012, 149(5):1060-1072. DIXON S J, LEMBERG K M, LAMPRECHT M R, et al. Ferroptosis: an iron-dependent form of nonapoptotic cell death[J]. Cell,2012, 149(5):1060-1072.
5、 DOLL S, FREITAS F P, SHAH R, et al. FSP1 is a glutathione-independent ferroptosis suppressor[J]. Nature,2019, 575(7784):693-698. DOLL S, FREITAS F P, SHAH R, et al. FSP1 is a glutathione-independent ferroptosis suppressor[J]. Nature,2019, 575(7784):693-698.
6、 BERSUKER K, HENDRICKS J M, LI Z, et al. The CoQ oxidoreductase FSP1 acts parallel to GPX4 to inhibit ferroptosis[J]. Nature,2019, 575(7784):688-692. BERSUKER K, HENDRICKS J M, LI Z, et al. The CoQ oxidoreductase FSP1 acts parallel to GPX4 to inhibit ferroptosis[J]. Nature,2019, 575(7784):688-692.
7、 STOCKWELL B R, FRIEDMANN ANGELI J P, BAYIR H, et al. Ferroptosis: a regulated cell death nexus linking metabolism, redox biology, and disease[J]. Cell,2017, 171(2):273-285. STOCKWELL B R, FRIEDMANN ANGELI J P, BAYIR H, et al. Ferroptosis: a regulated cell death nexus linking metabolism, redox biology, and disease[J]. Cell,2017, 171(2):273-285.
8、 WANG M, MAO C, OUYANG L, et al. Correction to: Long noncoding RNA LINC00336 inhibits ferroptosis in lung cancer by functioning as a competing endogenous RNA[J]. Cell Death Differ,2020, 27(4):1447. WANG M, MAO C, OUYANG L, et al. Correction to: Long noncoding RNA LINC00336 inhibits ferroptosis in lung cancer by functioning as a competing endogenous RNA[J]. Cell Death Differ,2020, 27(4):1447.
9、 YANG Y, TAI W, LU N, et al. lncRNA ZFAS1 promotes lung fibroblast-to-myofibroblast transition and ferroptosis via functioning as a ceRNA through miR-150-5p/SLC38A1 axis[J]. Aging (Albany NY),2020, 12(10):9085-9102. YANG Y, TAI W, LU N, et al. lncRNA ZFAS1 promotes lung fibroblast-to-myofibroblast transition and ferroptosis via functioning as a ceRNA through miR-150-5p/SLC38A1 axis[J]. Aging (Albany NY),2020, 12(10):9085-9102.
10、 MAO C, WANG X, LIU Y, et al. A G3BP1-interacting lncRNA promotes ferroptosis and apoptosis in cancer via nuclear sequestration of p53[J]. Cancer Res,2018, 78(13):3484-3496. MAO C, WANG X, LIU Y, et al. A G3BP1-interacting lncRNA promotes ferroptosis and apoptosis in cancer via nuclear sequestration of p53[J]. Cancer Res,2018, 78(13):3484-3496.
11、 WANG M, MAO C, OUYANG L, et al. Long noncoding RNA LINC00336 inhibits ferroptosis in lung cancer by functioning as a competing endogenous RNA[J]. Cell Death Differ,2019, 26(11):2329-2343. WANG M, MAO C, OUYANG L, et al. Long noncoding RNA LINC00336 inhibits ferroptosis in lung cancer by functioning as a competing endogenous RNA[J]. Cell Death Differ,2019, 26(11):2329-2343.
12、 MATHEW R, KARANTZA-WADSWORTH V, WHITE E. Role of autophagy in cancer[J]. Nat Rev Cancer,2007, 7(12):961-967. MATHEW R, KARANTZA-WADSWORTH V, WHITE E. Role of autophagy in cancer[J]. Nat Rev Cancer,2007, 7(12):961-967.
13、 LIANG C, ZHANG X, YANG M, et al. Recent progress in ferroptosis inducers for cancer therapy[J]. Adv Mater,2019, 31(51):e1904197. LIANG C, ZHANG X, YANG M, et al. Recent progress in ferroptosis inducers for cancer therapy[J]. Adv Mater,2019, 31(51):e1904197.
14、 HASSANNIA B, VANDENABEELE P, VANDEN BERGHE T. Targeting ferroptosis to iron out cancer[J]. Cancer Cell,2019, 35(6):830-849. HASSANNIA B, VANDENABEELE P, VANDEN BERGHE T. Targeting ferroptosis to iron out cancer[J]. Cancer Cell,2019, 35(6):830-849.
15、 STOCKWELL B R, FRIEDMANN ANGELI J P, BAYIR H, et al. Ferroptosis: a regulated cell death nexus linking metabolism, redox biology, and disease[J]. Cell,2017, 171(2):273-285. STOCKWELL B R, FRIEDMANN ANGELI J P, BAYIR H, et al. Ferroptosis: a regulated cell death nexus linking metabolism, redox biology, and disease[J]. Cell,2017, 171(2):273-285.
16、 DIXON S J, LEMBERG K M, LAMPRECHT M R, et al. Ferroptosis: an iron-dependent form of nonapoptotic cell death[J]. Cell,2012, 149(5):1060-1072. DIXON S J, LEMBERG K M, LAMPRECHT M R, et al. Ferroptosis: an iron-dependent form of nonapoptotic cell death[J]. Cell,2012, 149(5):1060-1072.
17、 GUO F, HIROSHIMA K, WU D, et al. Prohibitin in squamous cell carcinoma of the lung: its expression and possible clinical significance[J]. Hum Pathol,2012, 43(8):1282-1288. GUO F, HIROSHIMA K, WU D, et al. Prohibitin in squamous cell carcinoma of the lung: its expression and possible clinical significance[J]. Hum Pathol,2012, 43(8):1282-1288.
18、 MATSUOKA Y, TAKAGI Y, NOSAKA K, et al. Cytoplasmic expression of maspin predicts unfavourable prognosis in patients with squamous cell carcinoma of the lung[J]. Histopathology,2016, 69(1):114-120. MATSUOKA Y, TAKAGI Y, NOSAKA K, et al. Cytoplasmic expression of maspin predicts unfavourable prognosis in patients with squamous cell carcinoma of the lung[J]. Histopathology,2016, 69(1):114-120.
19、 WANG Q, LIU S, ZHAO X, et al. MiR-372-3p promotes cell growth and metastasis by targeting FGF9 in lung squamous cell carcinoma[J]. Cancer Med,2017, 6(6):1323-1330. WANG Q, LIU S, ZHAO X, et al. MiR-372-3p promotes cell growth and metastasis by targeting FGF9 in lung squamous cell carcinoma[J]. Cancer Med,2017, 6(6):1323-1330.
20、 MAO Y, YANG D, HE J, et al. Epidemiology of lung cancer[J]. Surg Oncol Clin N Am,2016, 25(3):439-445. MAO Y, YANG D, HE J, et al. Epidemiology of lung cancer[J]. Surg Oncol Clin N Am,2016, 25(3):439-445.
21、 QIAN L, LIN L, DU Y, et al. MicroRNA-588 suppresses tumor cell migration and invasion by targeting GRN in lung squamous cell carcinoma[J]. Mol Med Rep,2016, 14(4):3021-3028. QIAN L, LIN L, DU Y, et al. MicroRNA-588 suppresses tumor cell migration and invasion by targeting GRN in lung squamous cell carcinoma[J]. Mol Med Rep,2016, 14(4):3021-3028.
22、 YU K H, ZHANG C, BERRY G J, et al. Predicting non-small cell lung cancer prognosis by fully automated microscopic pathology image features[J]. Nat Commun,2016(7):12474. YU K H, ZHANG C, BERRY G J, et al. Predicting non-small cell lung cancer prognosis by fully automated microscopic pathology image features[J]. Nat Commun,2016(7):12474.
23、 PIPERDI B, MERLA A, PEREZ-SOLER R. Targeting angiogenesis in squamous non-small cell lung cancer[J]. Drugs,2014, 74(4):403-413. PIPERDI B, MERLA A, PEREZ-SOLER R. Targeting angiogenesis in squamous non-small cell lung cancer[J]. Drugs,2014, 74(4):403-413.
24、 OBERNDORFER F, LLAUER L. Molecular pathology of lung cancer: current status and perspectives[J]. Curr Opin Oncol,2018, 30(2):69-76. OBERNDORFER F, LLAUER L. Molecular pathology of lung cancer: current status and perspectives[J]. Curr Opin Oncol,2018, 30(2):69-76.
25、 ZHANG Y, YANG Q, WANG S. MicroRNAs: a new key in lung cancer[J]. Cancer Chemother Pharmacol,2014, 74(6):1105-1111. ZHANG Y, YANG Q, WANG S. MicroRNAs: a new key in lung cancer[J]. Cancer Chemother Pharmacol,2014, 74(6):1105-1111.
26、 CHEUNG C H Y, JUAN H F. Quantitative proteomics in lung cancer[J]. J Biomed Sci,2017, 24(1):37. CHEUNG C H Y, JUAN H F. Quantitative proteomics in lung cancer[J]. J Biomed Sci,2017, 24(1):37.
27、 CHEN W J, TANG R X, HE R Q, et al. Clinical roles of the aberrantly expressed lncRNAs in lung squamous cell carcinoma: a study based on RNA-sequencing and microarray data mining[J].Oncotarget,2017,8(37):61282-61304. CHEN W J, TANG R X, HE R Q, et al. Clinical roles of the aberrantly expressed lncRNAs in lung squamous cell carcinoma: a study based on RNA-sequencing and microarray data mining[J].Oncotarget,2017,8(37):61282-61304.
28、 GAO L, GUO Y N, ZENG J H, et al. The expression, significance and function of cancer susceptibility candidate 9 in lung squamous cell carcinoma: A bioinformatics and in vitro investigation[J]. Int J Oncol,2019, 54(5):1651-1664. GAO L, GUO Y N, ZENG J H, et al. The expression, significance and function of cancer susceptibility candidate 9 in lung squamous cell carcinoma: A bioinformatics and in vitro investigation[J]. Int J Oncol,2019, 54(5):1651-1664.
29、 XU J, SHU Y, XU T, et al. Microarray expression profiling and bioinformatics analysis of circular RNA expression in lung squamous cell carcinoma[J]. Am J Transl Res,2018, 10(3):771-783. XU J, SHU Y, XU T, et al. Microarray expression profiling and bioinformatics analysis of circular RNA expression in lung squamous cell carcinoma[J]. Am J Transl Res,2018, 10(3):771-783.